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Abstract
Aggression shows large variation between individuals, with about 50% 
explained by genetic factors. Biomarkers related to aggression have been 
reported for lipid metabolism and for epigenetic marks. Methylation and 
blood lipid levels are not independent and differential methylation can be 
a consequence of variation in blood lipid levels. We hypothesized that the 
methylation level of such loci in blood can inform us if aggression is associated 
with long-term exposure to lipid levels. If this is the case, we expect to find 
that loci where methylation levels are influenced by lipid levels to show 
differential methylation in aggressive individuals. Such loci might complement 
classic lipid level measures as a biomarker for lipid-related disturbances in 
aggression. As a first step, we examined the association of lipid levels and 
related biomarkers with aggression in a large adult population cohort (N 
= 5,588) and in 31 monozygotic (MZ) twin pairs who were discordant for 
aggression, as well as 12 extremely discordant MZ pairs. Biomarkers were 
not significantly associated with aggression in the population cohort. In the 
discordant MZ pairs we identified significant within-pair differences for 
glucose and marginally significant differences for lipids and cytokines, with 
the more aggressive twin showing lower levels of glucose and low density 
lipoprotein cholesterol and higher levels of fibrinogen, C-reactive protein and 
interleukin-6. The analysis of epigenetic data in the MZ pairs discordant for 
aggression did not show enrichment for lipid cytosine guanine dinucleotides 
(CpGs) and we observed no enrichment of lipid CpGs in an epigenome-wide 
association study of aggression in the population cohort. These results did 
not support the hypothesis that lipid CpGs show differential methylation in 
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adult aggression. A next step will be to examine 
the role of biomarkers in aggression across the 
lifespan, including childhood, and to explore a more 
holistic biomarker approach, such as offered by 
metabolomics.
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Introduction
Interpersonal violence and aggression place an 
enormous burden on society. While the incidence 
rate of injuries due to interpersonal violence has 
globally declined by approximately 11% from 1990 
to 2013 and the disability-adjusted life year (DALY) 
rate has globally decreased by approximately 
19.1%, the number of years lived with aggression-
caused disability (YLD) is still high (12 YLD) [1]. 
In addition to the physical injuries sustained through 
violence, exposure to violence has negative health 
consequences throughout the lifespan, resulting in 
mental health and behavioral disorders and chronic 
diseases [2, 3]. Mental health problems are not only a 
consequence of exposure to violence. Inappropriate 
aggressive behavior is also part of a number of 
psychiatric disorders, such as conduct (CD) and 
oppositional defiant disorders (ODD), schizophrenia 
and substance use disorders [4] and a distinct feature 
of several single-gene human diseases such as glass 
syndrome [5]. 
Aggressive and antisocial behaviors are not 
limited to adults. In fact, physical aggression in 
preschool children is common, with a peak of 
aggressive behavior around age two. A steady 
decline is observed once children reach school 
age, with aggression continuing to decrease into 
early adulthood [6, 7]. A small group of children 
will continue to display aggressive behavior from 
childhood into adolescence and adulthood [8]. Twin-
family studies have shown that both genetic and 
environmental factors play a role in the longitudinal 
stability of aggressive behavior from childhood to 
adolescence [9-11]. Across all ages and aggression-
related problems, genetic factors account for 
approximately half of the phenotypic variance, with 
the other half due to environmental influences [12]. 
Epigenetic mechanisms may mediate the effects 
of the environment and the genome on complex 
traits by influencing the activity of gene expression. 
In humans, epigenetic processes are mostly studied 
by DNA methylation of candidate genes or across 
the entire genome. In most human tissues, DNA 
methylation occurs almost exclusively at cytosine 
guanine dinucleotides (CpGs). CpG sites tend to 
cluster in so-called CpG-islands, which in humans 
are often found in the promotor regions of genes [13, 
14]. DNA methylation changes during development 
and in response to the environment [13-15]. 
Previous candidate gene studies have focused on the 
methylation of genes involved in neurotransmitter or 
hormone regulation and genes encoding cytokines 
and their transcription factors. Hyper-methylation 
of promotor regions have been observed for the 
serotonin receptor gene (SLC6A4) in adults with 
childhood-limited physical aggression [16], for the 
oxytocin receptor gene (OXTR) in 4-16 year old 
boys with ODD and CD with increased callous-
unemotional (CU) traits [17] and for the monoamine 
oxidase A gene (MAO-A) in incarcerated adult 
males with antisocial personality disorder (APD) 
[18]. In contrast, hypo-methylation of the promotor 
has been observed for the glucocorticoid receptor 
gene (NR3C1) in young adults with lifetime 
externalizing problems [19] and for the serotonin 1B 
receptor gene (HTR1B) for 3-16 year old boys with 
increased CU traits [20]. Forty-eight genomic loci 
for interleukin-1α, 4, 6, 8 and 10 and 66 loci within 
the transcriptional regulators of these cytokines were 
differentially methylated in young adult males with 
childhood physical aggression compared to matched 
controls [21]. Genome-wide methylation studies in 
T-cells found 744 differentially methylated CpG 
sites in males and females with childhood physical 
aggression [22, 23], for 7 loci the cord blood was 
differentially methylated between children with 
early-onset CD problems and children with low CD 
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problems [24]. An epigenome-wide association study 
(EWAS) of adult aggression observed suggestive 
differential methylation for eight CpG sites and 
identified three additional suggestive markers in 
monozygotic (MZ) twins who were discordant 
for aggression [25]. These studies demonstrated 
an association between DNA methylation and 
aggression at various loci. It remains, however, 
unclear which of these associations reflect a causal 
effect of DNA methylation on aggression and at 
which loci methylation differences are a marker of 
environmental exposures associated with aggression, 
or the result of aggressive behavior. 
Epigenetic studies of aggressive behavior are 
relatively recent. Classical biomarker studies 
of aggression focused on blood or urine-based 
measures, such as lipids, cytokines, and stress 
hormones, with most consistent results found for 
lipids. Lipids play an important role in influencing 
the physical properties of cell membranes and cell 
signaling in the brain. While studies in humans have 
only reported associations of altered brain lipid levels 
and psychiatric disorders such as major depres-
sive disorder or schizophrenia, it is believed that 
disturbances in lipid homeostasis could cause brain 
abnormalities and contribute to the development of 
psychiatric disorders [26]. Serum or plasma levels 
of lipids in humans and in non-human primates have 
been frequently explored as potential biomarkers of 
different types of aggressive behaviors, including 
violence, self-harm, and suicidal behavior, with 
violent criminal offenders and suicidal individuals 
having lower lipid levels as compared with controls 
[27, 28]. Low serum cholesterol levels have also 
been associated with early-onset CD disorder in 
non-violent criminal offenders diagnosed with APD 
[29]. Eriksen et al. (2017) observed an association of 
low high density lipoprotein (HDL) at admission of 
an acute psychiatric ward with violence in both men 
and women during hospital stay and for men in the 
first three months post-discharge [30]. Aggression 
subtypes have also been studied in relation with 
lipid levels. Conklin and Stanford (2008) reported a 
relationship of high cholesterol levels with increased 
premeditated aggression, but no associations of 
impulsive aggression and lipid levels [31]. Troisi 
and D’Argenio (2006) found that self-reported 
verbal aggression, hostility and anger in adults at 
risk for aggressive behavior was associated with 
decreased lipid levels; in contrast self-reported 
physical aggression was associated with an increase 
in low density lipoprotein (LDL) cholesterol levels 
only [32]. Most studies looked at associations 
between lipids and aggression, but some studies 
also support a causal effect of lipids on aggression. 
In monkeys, lowering of cholesterol levels through 
dietary intervention leads to behavioral changes, 
most notably in the number of incidents of contact 
aggression [33]. In humans, an increase in aggressive 
behaviors tended to be associated with lower levels of 
total cholesterol and HDL cholesterol. Especially in 
participants with low baseline aggression, lowering 
cholesterol levels by statins decreased aggression in 
younger men (under age 40) but generally increased 
aggression in postmenopausal women [34].
An interesting connection exists between 
the ‘older’ lipid biomarkers of aggression and 
the ‘newer’ epigenetic biomarkers, for which a 
plausible causal biological hypothesis may be 
formulated. A recent study identified 26 CpGs for 
which methylation levels were associated with 
blood lipid levels, and hypothesized that DNA 
methylation status of circulating immune cells might 
reflect long-term exposure to blood lipids [35]. To 
examine the causal relationship between lipid levels 
and genome-wide DNA methylation a stepwise 
Mendelian randomization analysis was performed, 
which showed that differential methylation was the 
consequence of variation in blood lipid levels and 
not vice versa. Triglyceride levels had a causal effect 
on 5 CpG sites, 1 CpG site was causally influenced 
by LDL and HDL had a causal effect on 2 CpG sites. 
The CpG sites were associated with expression levels 
of genes involved in lipid metabolism (CPT1A, 
SREBF1, DHCR24 and ABCG1), suggesting that 
methylation of these loci is involved in feedback 
control of lipid metabolism. These observations led 
us to hypothesize that the methylation level of these 
loci in blood can inform us if aggression is associated 
with long-term exposure to increased or decreased 
lipid levels: if this is the case, we expect to find that 
loci where methylation levels are influenced by lipid 
levels show differential methylation in aggressive 
individuals, and such loci might complement classic 
lipid level measures as a biomarker for lipid-related 
disturbances in aggression. 
The aim of the current study was to investigate 
previously reported and novel biomarkers of adult 
aggression. We analyzed (1) biomarkers identified in 
the review by Hagenbeek et al. (2016) [36], namely 
HDL, LDL and total cholesterol, cholesterol ratios, 
C-reactive protein (CRP), interleukin-6 (IL-6), and 
(2) biomarkers which are related to these previously 
identified lipid biomarkers, i.e. triglycerides, six 
glucose metabolism markers and inflammatory 
markers, to test for associations of these biomarkers 
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with aggression in a large population-based twin-
family sample from the Netherlands Twin Register 
(NTR; N = 5,588). Secondly, we employed a 
discordant MZ twin design, for which we selected 
MZ twins discordant for aggression, to test for mean 
biomarker differences between the MZ discordant 
twins. The discordant MZ twin design, or co-twin 
control design, can be viewed as an extension of 
a case-control design, as its application allows 
an insight into the origin (confounding effects 
versus similar genetic/environmental factors) of 
observed associations between traits [37, 38]. 
Next, we addressed the hypothesis that aggressive 
behavior is associated with methylation levels at 
loci involved in lipid metabolism by testing whether 
21 methylation sites associated with lipid levels as 
reported by Dekkers et al. (2016) [35] are enriched 
in the aggression EWAS [25]. In a last step, we 
compared the methylation status of these 21 sites in 
the aggression discordant twin pairs.
Materials and methods
Subjects
Twins and their family members registered with 
NTR [39] were visited at home to collect fasting 
blood and urine samples. Informed consent was 
obtained from all participants. The NTR Biobank 
study was approved by the Central Ethics Committee 
on Research Involving Human Subjects of the 
VU University Medical Centre, Amsterdam (IRB/
institute code NTR 03-180). 
We selected individuals who were over 18 years 
with biomarker and aggression data (N = 5,588, 
range = 18-84 years, mean age at blood sampling 
= 41.3 years, SD = 13.7, females = 66.6%). The 
dataset included 3,041 twins, their parents (1,172), 
siblings (1,067), spouses (291), and offspring 
(13). There were 1,814 MZ and 1,222 dizygotic 
(DZ) twins from 1,992 families. Subjects on lipid-
lowering medication (N = 683) or who failed to 
adhere to the fasting protocol (N = 489) were 
excluded from analyses of lipid levels. For glucose 
metabolism traits, subjects on medication impacting 
the Hypothalamic Pituitary Adrenal (HPA)-axis 
(N = 70), who took diabetes medication (N = 258), 
or who failed to adhere to the fasting protocol (N 
= 489) were excluded. For CRP, Tumor Necrosis 
Factor alpha (TNF-α), IL-6, soluble form of the IL-6 
receptor (sIL-6R) and fibrinogen, subjects on anti-
inflammatory medication (N = 385) or medication 
impacting the HPA-axis (N = 70) were excluded. 
Aggression data from NTR surveys closest to blood 
draw were selected. For the majority of individuals 
aggression was assessed after blood draw (N = 
5,196, range: 1-11 years after blood draw, mean = 
-3.6 year, SD = 1.96), for another 264 participants 
aggression was assessed prior to the blood draw 
(range: 1-8 years before blood draw, mean = 2.1, SD 
= 0.7). Aggression was assessed in the same year as 
the blood draw for 128 individuals.
Biomarker assessment
Lipids 
HDL cholesterol (mmol/l), total cholesterol 
(mmol/l) and triglycerides (mmol/l) were 
determined with the Vitros 250 assays (Johnson 
& Johnson, Rochester, USA) in heparin plasma. 
LDL (mmol/l) was estimated by the Friedewald 
formula [40]. HDL-cholesterol values of 6 or higher 
were excluded. Triglyceride values had a skewed 
distribution, therefore the values were log-normal 
transformed prior to outlier removal (values ± 4 SD 
from the mean).
Glucose metabolism 
Insulin (µlU/ml) and glucose (mmol/l) were 
determined in plasma using the Immulite 1000 
Insulin Method (Diagnostic Product Corporation, 
Los Angeles, USA) and the Vitros 250 Glucose array 
(Johnson & Johnson, Rochester, USA). Glycated 
hemoglobin (HbA1c; in percentages) was determined 
in EDTA plasma using the Nyocard HbA1c assay 
(Axis-Shield, Oslo, Norway). Homeostatic model 
assessments (HOMA) quantified insulin resistance 
and beta-cell function. The homeostatic model 
assessment of β-cell functioning (HOMA2-B) and 
insulin resistance (HOMA2-IR) were calculated 
from the fasting insulin and fasting glucose 
according to standard formulae [41]. For individuals 
with glucose values of 7 or higher glucose, insulin 
and HOMA measurements were excluded; outliers 
(values ± 4 SD from the mean) were removed for 
HbA1c. The insulin and HOMA variables were log-
normal transformed.
Inflammatory markers 
TNF-α (pg/ml), IL-6 (pg/ml) and sIL-6R (pg/ml) 
were measured in EDTA plasma by UltraSensitive 
ELISA (R&D systems, Minneapolis, USA, 
Quantikine HS HSTA00C). The Immulite 1000 
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CRP assay (Diagnostic Product Corporation, USA) 
determined CRP levels (mg/l) in heparin plasma. 
Fibrinogen levels (g/l) were determined by STA 
Compact Analyzer (Diagnostica Stago, France) in 
CTAD plasma. Outlying values (> 15 for CRP, IL-6 
and TNF-α, > 6 for fibrinogen and > 100,000 for 
sIL-6R) were excluded. CRP, TNF-α and IL-6 were 
log-normal transformed [42]. 
Anthropometric, health and lifestyle measures
Height (cm), weight (kg), hip and waist 
circumference (cm) were obtained during the home 
visit and Body Mass Index (BMI: weight [kg] / 
[height (cm)]2) and waist-to-hip ratio (WHR) were 
calculated. Information on medication use in the past 
six months and smoking status (1, never smokers; 2, 
former smokers; and 3, current smokers) was also 
obtained during the home visit. 
Aggression assessment
Aggression was assessed by the ASEBA Adult 
Self-Report (ASR) ‘Aggression Syndrome Scale’, 
which sums 15 aggression items, resulting in a sum 
score ranging from 0 to 30 [43], in NTR Survey 8 
(2009) or Survey 10 (2013). ASR aggression data 
were available for 4,858 individuals for Survey 8 
and 3,053 individuals for Survey 10. The survey 
closest to the age of blood draw was selected when 
both questionnaires had been filled out [25]. 
Statistical analyses
We conducted three types of analyses, as detailed 
below. Correction for multiple testing was done by 
Bonferroni correction for the number of independent 
variables (α = 0.05/N independent variables), 
separately for the confirmatory analyses of the 7 
previously described biomarkers [36], and for the 
exploratory analyses of 10 additional biomarkers 
and six anthropometric traits, resulting in two 
distinct alphas for the confirmatory and exploratory 
analyses. Matrix Spectral Decomposition [44] was 
applied (implemented in R [45]), to estimate the 
number independent variables in the correlation 
matrix of the dependent variables. A correlation 
matrix between all biomarkers (after applying all 
exclusion criteria, but not limiting to individuals 
with aggression data; N = 6,290) was used as input. 
For the confirmatory analyses five independent 
dimensions were seen, resulting in an alpha of 0.01. 
The second set of biomarkers could be reduced to 
eleven independent variables, resulting in an alpha 
of 0.004 for the exploratory analyses. Whenever 
we refer to marginally significant results, we refer 
to p-values of ≤ 0.05 ≥ 0.01 for the confirmatory 
analyses and ≤ 0.05 ≥ 0.004 for the exploratory 
analyses. 
Association of biomarkers and aggressive behavior 
To test the association between aggressive 
behavior and biomarkers, generalized estimation 
equation (GEE) models were fitted with the 
R-package GEE using the Gaussian link function 
for continuous data and the ‘exchangeable’ option 
to correct for the correlation structure due to family 
resemblance using 100 iterations. Three different 
models were evaluated: in the first model aggressive 
behavior, sex, age at blood sampling, smoking status, 
and BMI were the predictors with the lipids, glucose 
metabolism, and inflammatory markers as outcome 
variables. In the second model weight, BMI, WHR, 
hip and waist circumference were the outcome 
variables with aggressive behavior, sex, age at 
blood sampling, and smoking status (never, former, 
current smoker) as predictors. In model 3 height was 
the outcome variable with aggressive behavior, sex, 
year of birth, and smoking status as predictors. In 
models 2 and 3 we explored a potential relationship 
of the anthropometric traits with aggressive behavior 
to determine whether these traits should be added as 
extra covariates to our biomarker model. All models 
were repeated using a dichotomized ‘case/control’ 
aggression variable based on a T-score cut-off of 65, 
indicating the subclinical threshold for aggressive 
behavior [43]. For males and females separate sex-
specific T-scores were calculated for 18-35 year olds, 
36-59 year olds, and individuals over 60 years of 
age. All GEE models were applied to data in which 
individuals with missing data on the covariates were 
excluded.
Discordant monozygotic twin pair analyses 
Discordance in MZ twin pairs was defined based 
on within-pair differences in aggression scores of 
≥ 7 points in the survey closest to the moment of 
blood draw [25]. For MZ pairs with longitudinal 
aggression data, the within-pair difference had to 
be at least ≥ 7 points at one survey moment and ≥ 
5 points at the other survey moment. Aggression 
scores were available for both twins in 620 MZ 
pairs who took part in NTR Biobank, of which 264 
pairs had longitudinal data. Based on the criteria 
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for discordance 31 MZ pairs were discordant for 
aggression, where discordance was supported by 
longitudinal data for 6 pairs. Linear regression was 
used to adjust the biomarkers for the covariates. 
Mean differences in the residual biomarker levels 
were tested in a MZ-discordant design by paired 
t-tests applied in R. 
Enrichment analysis 
Tab. 1 provides an overview of the 28 lipid 
associated CpGs by Dekkers et al. [35]. An 
enrichment test was performed to examine if CpGs 
associated with lipids have lower p-values for 
aggression than expected by chance. To this end 
test statistics from the EWAS of aggression [25] 
were regressed on a variable indicating whether a 
CpG is significantly associated with lipids (1) or not 
(0). These analyses were performed for all CpGs 
significantly associated with lipids and present in the 
aggression EWAS (21/28 CpGs).
Results
Characteristics of the aggression data are 
described in Tab. 2. Adult females had higher 
aggression scores than males (β = 0.444, SE = 
0.084, p = 1.07E-07), aggression declined with 
age (β = -0.026, SE = 0.003, p = 2.98E-18) and 
‘never smokers’ were less aggressive than ‘former’ 
or ‘current’ smokers (β = -0.278, SE = 0.056, 
p = 8.90E-07). When performing the analyses 
on a dichotomized aggression phenotype, the 
association of aggression with smoking was still 
significant. No association between aggression and 
Table 1. Overview of the 28 cytosine guanine dinucleotide 
(CpG) sites reported by Dekkers et al. (2016) [35] to be 
significantly associated with lipid levels.
Lipid cgid Chromosome Position
Triglycerides
cg14476101 1 120,255,993
cg19693031 1 145,441,553
cg06690548 4 139,162,809
cg05575921 5 373,379
cg14817490 5 392,921
cg06560379 6 44,231,306
cg19589396 8 103,937,375
cg07504977 10 102,131,013
cg11376147 11 57,261,199
cg00574958 11 68,607,623
cg17058475 11 68,607,738
cg12556569 11 116,664,040
cg15863539 17 17,716,951
cg20544516 17 17,717,184
cg11024682 17 17,730,095
cg08857797 17 40,927,700
cg03636183 19 17,000,586
cg02711608 19 47,287,965
cg27243685 21 43,642,367
cg01881899 21 43,652,705
cg06500161 21 43,656,588
LDL-C
cg27168858 1 55,351,660
cg00908766 1 109,817,497
cg05119988 4 166,251,190
HDL-C
cg17901584 1 55,353,707
cg26313301 19 11,219,616
cg27243685 21 43,642,367
cg06500161 21 43,656,588
LDL: low density lipoprotein; HDL: high density lipoprotein.
In bold are the CpGs causally influenced by lipids.
Table 2. Characteristics of the Netherlands Twin Register (NTR) aggression data for Biobank project participants.
Data/analysis group
ASR aggression score Age at Survey Age at blood draw Sex
N Mean Median SD Min Max Mean Median SD Mean Median SD Female (%)
Survey 8 4,858 2.6 2 2.9 0 24 42 42 14 40 40 14 66.3%
Survey 10 3,053 2.6 2 2.9 0 21 43.6 42 10.9 36.5 35 10.6 69.3
EFA/GEE modelsa 5,588 2.6 2 3 0 24 44.6 42 13.9 41.3 38 13.7 66.6%
Discordant 
MZ twins
High 
aggression 31 11.5 10 3.7 7 23 36.7 37 12.4 33.8 33.1 11.7 81%
Low 
aggression 31 1.8 1 2.2 0 10 36.8 37 12.3 33.6 33.1 11.5 81%
Extremely 
discordant 
MZ twins
High 
aggression 12 14.5 13 3.9 10 23 32.7 32.5 11.2 29.4 28.8 10.1 66.6%
Low 
aggression 12 2 1 2.8 0 10 32.8 32.2 11.1 29.6 29.2 10 66.6%
ASR: Adult Self-Report; EFA: exploratory factor analyses; GEE: generalized estimation equation models; MZ: monozygotic.
aAll NTR biobank individuals with Survey 8 or 10 data; aggression score and age at survey from the survey closest to date of blood draw.
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the anthropometric traits was observed for either the 
continuous or the dichotomized aggression trait.
Association analyses
For the confirmatory analyses of the 7 biomarkers 
previously identified in literature and for the 10 
related biomarkers in the exploratory analyses, 
we tested the association with aggression while 
correcting for sex, age at blood draw, smoking 
status, and BMI. We observed no association 
between aggression and biomarkers with either the 
continuous or dichotomized aggression (Tab. 3). 
To assess if specific items of the aggression scale 
associated with biomarkers we used exploratory 
factor analyses (EFA) models in which we included 
all ASEBA ASR aggression scale items and all 
blood biomarkers. If blood biomarkers would 
associate with specific aggression items these would 
be included in the same factor. However, including 
the blood biomarkers in the aggression EFA’s 
did not result in interpretable factors, with blood 
biomarkers clustering in different factors from the 
aggression items. In the four-factor solutions all 
aggression items clustered within the same factor 
and three factors with biomarkers, each including 4 
to 8 biomarkers. 
Discordant monozygotic twin pair analyses
Mean differences in the residual biomarker 
levels were tested in 31 MZ discordant twin pairs 
by paired t-tests. The ‘high’-aggressive MZ twin 
scored on average 9.7 points higher than his or 
her ‘low’-aggressive co-twin (Fig. 1A). After 
correction for multiple testing, we observed a 
significant mean difference in the exploratory 
analyses for glucose, with a mean difference of 
-0.271 (p = 0.003), and a marginally significant 
mean difference for fibrinogen (mean difference = 
0.430, p = 0.01; Tab. 4). We checked whether the 
mean differences in MZ aggression discordant twins 
could be explained solely by extremely discordant 
pairs (≥ 10 points difference for aggression 
score). Twelve MZ pairs met the criteria for being 
extremely discordant (Tab. 2), with on average a 
12.5 point difference in aggression scores for the 
low- versus the high-scoring twin (Fig. 1B). The 
observed trend towards significance for fibrinogen 
seemed to be driven by extremely discordant MZ 
twin pairs. After multiple testing, fibrinogen was 
not significant in the extremely discordant MZ 
twin pairs, however, we did observe a larger mean 
Table 3. Generalized estimation equation (GEE) model 
results for the association of biomarker levels with 
aggressive behavior (and covariates).
Smok.: smoking; BMI: Body Mass Index; HbA1c: glycated hemo-
glo bin; LDL: low density lipoprotein; HDL: high density lipo protein; 
CRP: C-reactive protein; TNF-α: Tumor Necrosis Factor alpha; IL-6: 
in ter leu kin-6; sIL-6R: soluble form of the IL-6 receptor; HOMA2-B: 
the homeostatic model assessment of β-cell functioning; HOMA2-S: 
the homeostatic model assessment of insulin sensitivity; HOMA2-
IR: the homeostatic model assessment of insulin resistance.
ap-value threshold corrected for multiple testing for the confirmatory 
analyses (includes: CRP, LDL, IL6, LDL:HDL ratio, HDL:CHOL 
ratio and HDL) is p ≤ .01 and p ≤ .004 for the exploratory analyses 
(anthropometric traits, fibrinogen, insulin, glucose, HOMA2-S, 
HOMA2-IR, HOMA2-B, HbA1c, sIL-6R, TNF-α and triglycerides).
N
Estim
ates
Robust SE
P-value
a
AGG
Sex
Age
Sm
ok.
BMI
AGG
Sex
Age
Sm
ok.
BMI
AGG 
Sex
Age
Sm
ok.
BMI
HbA1c
4,988
.0025
.0287
.0065
-.0159
.0078
.0023
.0149
.0005
.0095
.0019
.2833
.0542
2.14E-32
.0951
3.70E-05
Glucose 
5,035
-.0021
-.1618
.0106
-.0358
.0287
.0023
.0152
.0006
.0091
.0020
.3612
1.81E-26
4.49E-75
7.84E-05
4.26E-46
Insulin
4,935
-.0031
-.0319
-.0012
-.0244
.0639
.0025
.0168
.0006
.0111
.0022
.2175
.0580
.0469
.0279
1.60E-184
T-cholesterol
4,958
-.0015
.0376
.0322
-.0693
.0251
.0045
.0302
.0011
.0176
.0037
.7375
.2129
2.21E-196
8.67E-05
1.31E-11
LDL
4,953
-.0024
-.0980
.0262
-.0314
.0274
.0040
.0279
.0010
.0165
.0035
.5441
.0004
6.38E-154
.0569
4.08E-15
HDL
4,958
.0012
.2668
.0039
.0160
-.0277
.0016
.0102
.0004
.0065
.0013
.4397
8.38E-151
3.29E-21
.0131
7.88E-106
HDL:CHOL 
4,957
.0005
.0500
-.0011
.0062
-.0069
.0004
.0024
.0001
.0015
.0003
.1754
2.87E-93
1.73E-32
3.44E-05
3.33E-117
LDL:HDL 
4952
-.0037
-.5277
.0133
-.0778
.0660
.0041
.0305
.0010
.0179
.0036
.3628
4.86E-67
4.09E-38
1.39E-05
1.74E-73
Triglycerides
4951
.0000
-.1799
.0035
-.0732
.0360
.0021
.0144
.0005
.0084
.0017
.9883
5.08E-36
1.59E-12
3.09E-18
6.12E-102
CRP
5100
-.0084
.4177
-.0029
-.1040
.1099
.0053
.0322
.0012
.0198
.0038
.1135
1.89E-38
.0146
1.56E-07
5.34E-183
Fibrinogen
4973
.0023
.2030
.0075
-.0343
.0462
.0031
.0189
.0008
.0125
.0026
.4739
7.05E-27
1.09E-22
.0060
9.18E-71
TNF-α 
5047
.0021
.0092
.0030
-.0026
.0137
.0028
.0178
.0007
.0112
.0023
.4425
.6072
6.12E-06
.8182
2.55E-09
IL-6
5040
-.0016
.0596
.0098
-.1003
.0416
.0032
.0193
.0007
.0122
.0022
.6195
.0020
8.75E-42
1.58E-16
1.21E-80
sIL-6R 
5064
-36.1944
-1001.0
108.28
27.0819
224.71
52.418
343.86
12.74
208.28
44.15
.4899
.0036
1.95E-17
.1947
3.59E-07
HOMA2-B
4570
-.0010
.0330
-.0045
.0008
.0262
.0014
.0101
.0004
.0062
.0013
.4895
.0011
9.83E-36
.9026
8.99E-88
HOMA2-S
4570
.0028
.0502
.0002
.0167
-.0519
.0022
.0147
.0005
.0091
.0020
.1933
.0006
.6652
.0671
4.35E-154
HOMA2-IR
4570
-.0026
-.0511
-.0003
-.0162
.0519
.0022
.0148
.0005
.0092
.0020
.2279
.0006
.6040
.0766
1.12E-154
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difference and smaller p-value than for the overall 
group of discordant MZ pairs (mean difference = 
0.669, p = 0.008). The opposite is true for glucose, 
after excluding the least discordant twin pairs for 
aggression (Δ ≥ 7 < 10), we no longer observed 
a significant hit (mean difference = -0.156, p = 
0.189). The analysis on extremely discordant 
MZ pairs also resulted in marginally statistically 
significant findings for the association between 
aggression and CRP (mean difference = 1.082, 
p = 0.016), LDL cholesterol (mean difference = 
-0.446, p = 0.038), and IL-6 (mean difference = 
0.785, p = 0.045). Estimates and p-values for the 
analyses including the extremely discordant MZ 
pairs can be found in Tab. 4. 
Enrichment analysis of lipid methylation markers in 
the aggression epigenome-wide association study
None of the CpGs associated with lipids was 
strongly or significantly associated with aggres-
sion in the entire NTR cohort and none of the 
CpGs showed a significant methylation difference 
between MZ twins discordant for aggression. 
CpGs associated with lipids were also not 
significantly enriched in the EWAS of aggression 
Figure 1. Adult Self-Report (ASR) aggression scores of aggression-discordant monozygotic (MZ) twins. A. Aggression 
scores of discordant MZ twins (≥ 7 points difference). B. Aggression scores of extremely discordant MZ twins (≥ 10 points 
difference).
Aggression discordance is defined as ≥ 7 points difference on the ASR aggression sum score; with extreme discordance defined as ≥ 
10 points difference. The ASR aggression scores for the survey closest to blood draw are plotted for low- and high-scoring twins of 31 
discordant MZ pairs (A) and 12 extremely discordant MZ twin pairs (B). The scores of co-twins are connected by lines.
A. B.
Table 4. Top paired t-test results of residual biomarker levels between aggression discordant monozygotic (MZ) twins.
Biomarker
Low-scoring twin High-scoring twin
Mean differencea p-valueb
Mean SD Mean SD
Aggression discordant MZ twins (N = 31)
Glucose 5.3 0.5 5.1 0.5 -0.271 0.003
Fibrinogen 2.7 0.7 3.0 0.8 0.430 0.010
Extremely aggression discordant MZ twins (N = 12)
Fibrinogen 2.6 0.8 3.0 0.8 0.669 0.008
CRP 2.4 3.1 3.2 3.7 1.082 0.016
LDL 3.2 1.0 2.6 0.8 -0.446 0.038
IL-6 1.5 1.0 2.4 1.7 0.785 0.045
MZ: monozygotic; CRP: C-reactive protein; LDL: low density lipoprotein; IL-6: interleukin-6.
aMean difference in residual biomarker level between aggression-discordant twins; bsignificant after correcting for multiple testing; p ≤ 0.01 
confirmatory analyses; p ≤ 0.004 exploratory analyses.
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in the entire NTR cohort or in discordant MZ twins 
(Tab. 5).
Discussion
We examined the association of lipid levels with 
adult aggression in a large population-based sample 
and in discordant MZ twin pairs. No significant 
associations were seen, though the analysis in the 
MZ twins extremely discordant for aggression found 
a marginally significant (p = 0.038) association 
of decreased LDL cholesterol levels in the more 
aggressive twin, congruent with previous studies 
showing decreased LDL levels for aggression 
[46] and suicidality in younger individuals [28]. 
However, physical aggression was previously 
characterized by increased LDL levels [32]. In 31 
pairs of MZ twin pairs discordant for aggression 
we identified a significant association with glucose 
levels, where the twins with high aggression had 
decreased glucose levels. The analyses in MZ twins 
extremely discordant for aggression also revealed 
marginally significant results for cytokine levels, 
where elevated cytokine levels were observed for 
the high-scoring twins. Dekkers et al. [35] used 
Mendelian randomization to show that circulating 
lipid levels influence DNA methylation and a 
study of methylation and adult aggression found 
suggestive evidence for several associations [25]. 
We hypothesized that the methylation level of 
lipid loci in blood can inform us if aggression is 
associated with long-term exposure to increased 
or decreased lipid levels, but found no significant 
enrichment of the lipid CpG sites in the aggression 
EWAS [25]. 
Discordant MZ analyses identified low glucose 
as potential biomarker for aggression. Glucose 
levels in high-scoring twins ranged from 4.4-6.4, 
with mean glucose levels of 5.1 (SD = 0.5), while 
these levels ranged from 4.3-6.5 in low-scoring 
twins with a mean of 5.3 (SD = 0.5). The observed 
low glucose levels in the more aggressive MZ twins 
is no longer significant when concentrating on the 12 
MZ twin pairs extremely discordant for aggression. 
One explanation might be reduced power, an 
alternative explanation might be an increase of 
insulin resistance in these twins, leading to higher, 
rather than lower, glucose levels. However, while no 
longer significant, we still observe a trend for lower 
glucose levels in the more aggressive MZ twins. 
In addition, insulin resistance itself (HOMA2-IR) 
is not significantly associated with aggression in 
either of GEE analyses (Tab. 3) or our discordant 
MZ analyses. Similar to the current study, in a 
sample of 107 married couples, small but significant 
associations of low evening glucose levels with both 
aggressive impulses (β = -0.008, t(213) = -2.82, p = 
0.006) and aggressive behavior (β = -0.003, t(206) 
= -5.63, p < 0.0001) were observed [47]. The low 
glucose levels as observed in the current study 
seem in contrast with previous studies reporting 
increased aggression in individuals with diabetes 
[48] or metabolic syndrome [49], both of which are 
characterized by high glucose levels. Together this 
might indicate that the relationship of glucose and 
aggression is non-linear, with aggressive behavior 
observed on both ends of the glucose distribution. 
We excluded individuals on diabetes medication 
(N = 258) from the analyses. For individuals on 
diabetes medication, aggression scores on Survey 8 
were available for 92 individuals with a range of 
0-8 and a mean aggression score of 1.9 (SD = 2.4). 
Survey 10 data were available for 23 individuals with 
aggression scores ranging from 0 to 6 (mean = 2.2, 
SD = 1.8). Aggression scores in these individuals 
were on average similar to the aggression scores 
observed in the total sample although the range is 
restricted in comparison.
Table 5. Enrichment results for all 21 cytosine guanine dinucleotides (CpGs) associated with lipids in the aggression 
epigenome-wide association study (EWAS) for the entire Netherlands Twin Register (NTR) cohort and in aggression 
discordant monozygotic (MZ) twins.
Estimate Std. Error t-value Pr (> |t|)
bootstrap 
Std. Error
bootstrap 
t-value
bootstrap 
p-value
EWAS of Aggression in the Entire NTR Cohort
(Intercept) 1.047 0.002 453.841 < 2e-16 0.0023 458.773 < 2e-16
Lipid CpGs 0.385 0.323 1.193 0.233 0.349 1.104 0.269
EWAS in discordant MZ twins
(Intercept) 0.828 0.0013 825.228 < 2e-16 0.0983 829.161 < 2e-16
Lipid CpGs 0.098 0.1403 0.701 0.483 0.1293 0.762 0.446
EWAS: epigenome-wide association study; NTR: the Netherlands Twin Register; CpGs: cytosine guanine dinucleotides.
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Within-pair differences for fibrinogen levels 
were marginally significant and showed a higher 
mean difference of 0.669 in extremely discordant 
pairs as compared to 0.430 in the total group 
of 31 discordant pairs. Fibrinogen levels range 
from 1.91-4.80 in the high scoring twins (mean = 
3.0, SD = 0.8) and 1.62-4.12 in the low-scoring 
twins (mean = 2.7, SD = 0.7); similarly, in the 12 
extremely discordant pairs these ranges were 2.23-
4.30 (mean = 3, SD = 0.8) and 1.62-4.00 (mean = 
2.6, SD = 0.8), respectively. In the 12 extremely 
discordant MZ twin pairs we also observed a trend 
for increased CRP and IL-6 levels in the high-
scoring twins. High-scoring twins had mean CRP 
values of 3.2 (SD = 3.7) and mean IL-6 values of 
2.4 (SD = 1.7) as compared with low-scoring twin 
with mean CRP values of 2.4 (SD = 3.1) and mean 
IL-6 values of 1.5 (SD = 1). Both human and animal 
studies have identified elevated cytokine levels in 
aggressive behavior [50]. This association was also 
observed for psychiatric disorders closely related to 
aggression, such as intermittent explosive disorder 
(IED) [51], personality disorders in adults [52] or 
severe affective and behavioral dysregulation in 
children [53]. However, lower levels of both pro- 
and anti-inflammatory cytokines also were observed 
in young adult males with a childhood chronic 
physical aggression trajectory [54]. Despite this 
contradiction it would appear that cytokine levels 
are associated with aggression and associations also 
were observed on an epigenetic level. Provençal 
et al. (2013) reported differential methylation of 
cytokine genomic loci and transcription factors in 
young adult males with a history of chronic physical 
aggression as compared with controls [54]. These 
loci were not replicated in a later EWAS study [25] 
which used a different technique to measure DNA 
methylation. While we found no evidence that the 
association of methylation and adult aggression is 
due to lipid levels, it is possible that variation in 
cytokine levels might explain this association.
This study has several strengths and limitations. 
It is one of the most comprehensive investigations 
of the role of classic biomarkers in aggression, 
utilizing a population-based sample, the powerful 
MZ discordant design, and including 17 blood 
biomarkers. While our large study represents 
biomarkers from three different classes, this list is 
far from exhaustive. Extensive research has been 
done to elucidate the role of neurotransmitters and 
hormones in aggression; with several hypotheses 
stating that the imbalance between hormones and 
neurotransmitter levels is responsible for aggressive 
behavior. For example, Montoya et al. (2012) 
proposed a dual-hormone serotonergic hypothesis 
[55], in which a high ratio of testosterone to cortisol 
levels is responsible for a general predisposition 
towards aggression with low prefrontal serotonergic 
functioning specifically predisposing towards social 
aggression. We might thus miss vital pieces of 
information in limiting our study to three classes 
of blood biomarkers. Future studies should attempt 
to be even more encompassing in the inclusion 
of biomarkers; preferably by including high-
throughput techniques such as metabolomics. 
Such studies should consider using multiple 
metabolomics platforms in their design in order to 
obtain a detailed account of various biochemical 
classes and their role in aggression. In addition 
to expanding the number of biochemical classes, 
we also recommend to study the biochemistry of 
aggression in other, preferably multiple, tissues, as 
metabolic flux is predicted to be tissue specific [56].
A limitation of a population-based sample is the 
lack of extremely aggressive individuals. While our 
sample covers both the normal and clinical range 
of the ASEBA ASR aggression scale [43], few 
individuals have (sub-)clinical aggression scores 
(T-scores > 65). We addressed this limitation by 
inclusion of the MZ discordant design. However, 
even in a large twin population, there were 
relatively small numbers of discordant twin pairs, 
as aggression is a heritable trait. Another strength 
of the current study is that it included subjects of 
a wide age-range (18-84 years) encompassing the 
human lifespan of early to late adulthood. However, 
this is a cross-sectional dataset which does not 
cover the entire human life-span. Currently, we can 
make no inferences about the role of biomarkers 
in childhood or adolescent aggression; where the 
biological underpinnings of aggression might differ 
from adult aggression. For example, for epigenetics, 
sex- and age-specific variation in the influence of 
genetic and environmental factors on methylation 
has been observed [57]. A next step will be to 
examine the role of biomarkers and epigenetics in 
aggression across the lifespan, including childhood 
and adolescence. 
A third strength is the comprehensive range 
of statistical methods used to elucidate the role 
of biomarkers in aggression, including EFA to 
investigate whether including biomarkers and 
aggression scale items in the same EFA would 
result in biologically interpretable factors. How-
ever, in the resulting four-factor model, biomarkers 
and aggression items clustered in separate factors. 
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Furthermore, the EFA with the best fit for the 
models including only the aggression items resulted 
in a three-factor solution. This is in contrast with 
the factor structure of childhood aggression, for 
which two aggression subtypes, relational and 
direct aggression, were identified [58]. A recent 
study suggested to discontinue the use of subtypes 
in disruptive behavior problems such as aggression 
and identified in factor mixture models a one-
class solution, suggesting we should move from 
distinct subtypes to a multidimensional approach to 
disruptive behavior problems [59]. Incorporating a 
multidimensional approach to biomarkers studies 
could lead towards improved diagnostic capabilities 
and aid in the development of ‘personalized 
medicine’ approaches for the treatment of 
aggression.
In conclusion, in MZ twin pairs discordant 
for aggression we found a significant association 
for lower glucose levels and a trend for higher 
fibrinogen levels in the twins scoring high for 
aggression. Repeating the analyses in 12 pairs of 
extremely aggression discordant MZ twin pairs also 
resulted in marginally significant findings for CRP, 
IL-6 and LDL cholesterol, while the association 
for glucose disappeared completely. We found no 
evidence for enrichment of lipid CpG sites in the 
aggression EWAS in the entire NTR cohort of in 
MZ twins discordant for aggression nor were lipids 
significantly associated to adult aggression in a 
large population-based sample.
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